BDSX
|Biodesix Inc
NASDAQ
USD 0.28
-0.01|-4.86%
Current Price
USD 0.28
Change
USD -0.01 (-4.86%)
P/E Ratio
Dividend Yield
Market Cap
50.77M
Volume
1.86M
Open
USD 0.29
Previous Close
USD 0.30
52-Week High
USD 2.04
52-Week Low
USD 0.17
About Biodesix Inc
Biodesix, Inc. operates as a diagnostic solutions company. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests markets as Nodify Lung Nodule Risk Assessment testing to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also provides GeneStrat ddPCR, GeneStrat NGS, and VeriStrat tests markets as part of IQLung testing strategy,...
Sector:Healthcare
Industry:Diagnostics & Research
CEO:Mr. Scott Hutton
Employees:273
Headquarters:Louisville, USA
Website:www.biodesix.com
Dividend History
Dividend Payments
| Declared Date | Record Date | Payment Date | Amount | Frequency |
|---|
Similar Companies
Explore Stocks by Sector
technology
finance
healthcare
Frequently Asked Questions